PL1931629T3 - Synteza inhibitorów reniny obejmująca reakcję cykloaddycji - Google Patents

Synteza inhibitorów reniny obejmująca reakcję cykloaddycji

Info

Publication number
PL1931629T3
PL1931629T3 PL06805861T PL06805861T PL1931629T3 PL 1931629 T3 PL1931629 T3 PL 1931629T3 PL 06805861 T PL06805861 T PL 06805861T PL 06805861 T PL06805861 T PL 06805861T PL 1931629 T3 PL1931629 T3 PL 1931629T3
Authority
PL
Poland
Prior art keywords
synthesis
cycloaddition reaction
renin inhibitors
inhibitors involving
involving
Prior art date
Application number
PL06805861T
Other languages
English (en)
Inventor
Stuart John Mickel
Wolfgang Marterer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35394904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1931629(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1931629T3 publication Critical patent/PL1931629T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
PL06805861T 2005-09-28 2006-09-26 Synteza inhibitorów reniny obejmująca reakcję cykloaddycji PL1931629T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0519764.5A GB0519764D0 (en) 2005-09-28 2005-09-28 Organic compounds
PCT/EP2006/009323 WO2007039183A1 (en) 2005-09-28 2006-09-26 Sythesis of renin inhibitors involving a cycloaddition reaction
EP06805861A EP1931629B1 (en) 2005-09-28 2006-09-26 Synthesis of renin inhibitors involving a cycloaddition reaction

Publications (1)

Publication Number Publication Date
PL1931629T3 true PL1931629T3 (pl) 2011-05-31

Family

ID=35394904

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06805861T PL1931629T3 (pl) 2005-09-28 2006-09-26 Synteza inhibitorów reniny obejmująca reakcję cykloaddycji

Country Status (27)

Country Link
US (2) US7973175B2 (pl)
EP (2) EP2287153A1 (pl)
JP (1) JP2009509990A (pl)
KR (1) KR20080048042A (pl)
CN (1) CN101273012A (pl)
AR (1) AR057137A1 (pl)
AT (1) ATE492533T1 (pl)
AU (1) AU2006299097B2 (pl)
BR (1) BRPI0616707A2 (pl)
CA (1) CA2623495A1 (pl)
DE (1) DE602006019114D1 (pl)
EC (1) ECSP088319A (pl)
ES (1) ES2358536T3 (pl)
GB (1) GB0519764D0 (pl)
GT (1) GT200600427A (pl)
IL (1) IL189763A0 (pl)
MA (1) MA29852B1 (pl)
MY (1) MY143251A (pl)
NO (1) NO20082005L (pl)
NZ (1) NZ566429A (pl)
PE (1) PE20070488A1 (pl)
PL (1) PL1931629T3 (pl)
PT (1) PT1931629E (pl)
RU (1) RU2423348C2 (pl)
TN (1) TNSN08142A1 (pl)
TW (1) TW200730480A (pl)
WO (1) WO2007039183A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
WO2011051853A1 (en) 2009-10-29 2011-05-05 CarboDesign LLC Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
CN101863796B (zh) * 2010-05-12 2011-08-24 海南美兰史克制药有限公司 一种阿利克仑化合物及其制法
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421295A1 (de) 1984-06-08 1985-12-12 Basf Ag, 6700 Ludwigshafen Neue pyrrolidincarbonsaeurederivative, verfahren zu ihrer herstellung
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
DE60138099D1 (de) 2000-07-05 2009-05-07 Speedel Pharma Ag Verfahren zur herstellung von substituierten octanoyl-amiden
DE10116816A1 (de) * 2001-04-04 2002-10-17 Basf Ag Verfahren zur Herstellung von N-Benzylaminen
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1931629A1 (en) 2008-06-18
GB0519764D0 (en) 2005-11-09
TW200730480A (en) 2007-08-16
ATE492533T1 (de) 2011-01-15
RU2008116317A (ru) 2009-11-10
RU2423348C2 (ru) 2011-07-10
CA2623495A1 (en) 2007-04-12
JP2009509990A (ja) 2009-03-12
NO20082005L (no) 2008-06-24
AU2006299097B2 (en) 2010-11-04
AU2006299097A1 (en) 2007-04-12
EP2287153A1 (en) 2011-02-23
PT1931629E (pt) 2011-03-09
MA29852B1 (fr) 2008-10-03
ECSP088319A (es) 2008-04-28
DE602006019114D1 (de) 2011-02-03
US7973175B2 (en) 2011-07-05
CN101273012A (zh) 2008-09-24
EP1931629B1 (en) 2010-12-22
US20110230665A1 (en) 2011-09-22
MY143251A (en) 2011-04-15
PE20070488A1 (es) 2007-06-13
BRPI0616707A2 (pt) 2011-06-28
IL189763A0 (en) 2008-08-07
WO2007039183A1 (en) 2007-04-12
NZ566429A (en) 2010-10-29
AR057137A1 (es) 2007-11-21
GT200600427A (es) 2007-04-30
US20080255369A1 (en) 2008-10-16
ES2358536T3 (es) 2011-05-11
TNSN08142A1 (en) 2009-07-14
KR20080048042A (ko) 2008-05-30

Similar Documents

Publication Publication Date Title
HRP20130793T1 (hr) Derivati 3-alkil-5-(4-alkil-5-okso-tetrahidrofuran-2-il)pirolidin-2-ona kao meä�uprodukti u sintezi inhibitora renina
SI2266961T1 (sl) Postopek za sintezo organskih spojin
GB0611405D0 (en) FKBP-L: A novel inhibitor of angiogenesis
EP1957474A4 (en) SYNTHESIS OF FTFZ INHIBITORS
HRP20130144T1 (en) Renin inhibitors
GB0504995D0 (en) Use of a compound
EP2162436A4 (en) NEW CASE OF RENININHIBITORS
IL189763A0 (en) Synthesis of renin inhibitors involving a cycloaddition reaction
HK1134295A1 (en) Compounds and methods for synthesis and purification of oligonucleotides
IL187004A0 (en) Process for preparing renin inhibitors
PL2468724T3 (pl) Synteza związków pirolidynowych
EP2184608A4 (en) NON-SPECIFIC REACTION INHIBITOR
EP1910272A4 (en) INHIBITORS OF THE RENINE
ZA200808419B (en) Primary amines as renin inhibitors
IL180678A0 (en) Methods for improving bioavailability of a renin inhibitor
HK1153189A1 (en) Convergent synthesis of renin inhibitors and intermediates useful therein
IL193905A0 (en) Renin inhibitors for the treatment of hypertension
ZA200709621B (en) Process for the synthesis of organic compounds
EP2128135A4 (en) PROCESS FOR THE SYNTHESIS OF A NITROXYL RADICAL
SI1812422T1 (sl) Kristalna oblika irbesartana
EP1959952A4 (en) CHEMICAL SYNTHESIS OF A VERY POWERFUL EPOTHILONE
IL162071A (en) Process for synthesis of dinitrotetraoxadiazaisowurtzitane (dtiw)
PL2035379T3 (pl) Inhibitory dehydrogenazy 11-beta-hydroksysteroidowej typu 1
GB0503343D0 (en) Methods of chemical synthesis
GB0522829D0 (en) Use of a compound